4.7 Article

IK1 Heterogeneity Affects Genesis and Stability of Spiral Waves in Cardiac Myocyte Monolayers

Journal

CIRCULATION RESEARCH
Volume 104, Issue 3, Pages 355-U158

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.108.178335

Keywords

Kir2.1; inwardly rectifying potassium current; reentry; spiral waves; ventricular tachycardia; ventricular fibrillation

Funding

  1. NHLBI NIH HHS [R01 HL066239-07, R01 HL066239, P01 HL077180-04, P01 HL077180, HL66239, P0-1 HL77180] Funding Source: Medline

Ask authors/readers for more resources

Previous studies have postulated an important role for the inwardly rectifying potassium current (I-K1) in controlling the dynamics of electrophysiological spiral waves responsible for ventricular tachycardia and fibrillation. In this study, we developed a novel tissue model of cultured neonatal rat ventricular myocytes (NRVMs) with uniform or heterogeneous Kir2.1expression achieved by lentiviral transfer to elucidate the role of I-K1 in cardiac arrhythmogenesis. Kir2.1-overexpressed NRVMs showed increased I-K1 density, hyperpolarized resting membrane potential, and increased action potential upstroke velocity compared with green fluorescent protein-transduced NRVMs. Opposite results were observed in Kir2.1-suppressed NRVMs. Optical mapping of uniformly Kir2.1 gene-modified monolayers showed altered conduction velocity and action potential duration compared with nontransduced and empty vector-transduced monolayers, but functional reentrant waves could not be induced. In monolayers with an island of altered Kir2.1 expression, conduction velocity and action potential duration of the locally transduced and nontransduced regions were similar to those of the uniformly transduced and nontransduced monolayers, respectively, and functional reentrant waves could be induced. The waves were anchored to islands of Kir2.1 overexpression and remained stable but dropped in frequency and meandered away from islands of Kir2.1 suppression. In monolayers with an inverse pattern of I-K1 heterogeneity, stable high frequency spiral waves were present with I-K1 overexpression, whereas lower frequency, meandering spiral waves were observed with I-K1 suppression. Our study provides direct evidence for the contribution of I-K1 heterogeneity and level to the genesis and stability of spiral waves and highlights the potential importance of I-K1 as an antiarrhythmia target. ( Circ Res. 2009; 104: 355-364.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Cardiac Autonomic Neuropathy Is Not Reversed by Euglycemia Following Islet Transplantation

Tejas Deshmukh, Peter Emerson, Patricia Anderson, Eddy Kizana, Philip J. O'Connell, D. Jane Holmes-Walker, James J. H. Chong

Summary: Cardiac autonomic neuropathy (CAN) is a significant issue for individuals with type 1 (T1D) and type 2 (T2D) diabetes. This study compared heart rate variability (HRV) among different groups, finding that CAN was not reversible in T1D patients post-islet cell transplantation at a median of 4 years. Differences in HRV parameters between control groups and T1D, as well as between control groups and T2D, suggest potential impacts of hypoglycemia on HRV.

TRANSPLANTATION (2021)

Article Microbiology

Proteomic Analysis of Non-human Primate Peripheral Blood Mononuclear Cells During Burkholderia mallei Infection Reveals a Role of Ezrin in Glanders Pathogenesis

Chih-Yuan Chiang, Yang Zhong, Michael D. Ward, Douglas J. Lane, Tara Kenny, Raysa Rosario-Acevedo, Brett P. Eaton, Sylvia R. Trevino, Taylor B. Chance, Meghan Hu, Patricia L. Worsham, David M. Waag, Richard T. Moore, Lisa H. Cazares, Christopher K. Cote, Yingyao Zhou, Rekha G. Panchal

Summary: Burkholderia mallei, the causative agent of glanders, poses a serious biological threat due to its infectivity, antibiotic resistance, and lack of approved vaccines. Studying host responses in non-human primates has revealed insights into the pathogenesis of glanders. Integration of proteomics data has led to the construction of a predictive protein-protein interaction network, shedding light on the molecular mechanisms underlying B. mallei infections.

FRONTIERS IN MICROBIOLOGY (2021)

Correction Multidisciplinary Sciences

A proximity-dependent biotinylation map of a human cell (vol 595, pg 120, 2021)

Christopher D. Go, James D. R. Knight, Archita Rajasekharan, Bhavisha Rathod, Geoffrey G. Hesketh, Kento T. Abe, Ji-Young Youn, Payman Samavarchi-Tehrani, Hui Zhang, Lucie Y. Zhu, Evelyn Popiel, Jean-Philippe Lambert, Etienne Coyaud, Sally W. T. Cheung, Dushyandi Rajendran, Cassandra J. Wong, Hana Antonicka, Laurence Pelletier, Alexander F. Palazzo, Eric A. Shoubridge, Brian Raught, Anne-Claude Gingras

NATURE (2022)

Article Medicine, Research & Experimental

Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties

Ryan P. Bennett, Elena N. Postnikova, Brett P. Eaton, Yingyun Cai, Shuiqing Yu, Charles O. Smith, Janie Liang, Huanying Zhou, Gregory A. Kocher, Michael J. Murphy, Harold C. Smith, Jens H. Kuhn

Summary: Sangivamycin is an antiviral drug that shows broad-spectrum activity against different viruses, including SARS-CoV-2. It demonstrates potent inhibitory effects on SARS-CoV-2 replication in various cell types, surpassing the efficacy of remdesivir. Pharmacokinetic and toxicity studies suggest favorable properties for clinical administration. Additionally, Sangivamycin has the potential for combination therapy and may help combat drug-resistant or vaccine-escaping SARS-CoV-2 variants.

JCI INSIGHT (2022)

Article Medicine, Research & Experimental

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants

Vanessa Monteil, Brett Eaton, Elena Postnikova, Michael Murphy, Benedict Braunsfeld, Ian Crozier, Franz Kricek, Janine Niederhofer, Alice Schwarzbock, Helene Breid, Stephanie Devignot, Jonas Klingstrom, Charlotte Thalin, Max J. Kellner, Wanda Christ, Sebastian Havervall, Stefan Mereiter, Sylvia Knapp, Anna Sanchez Jimenez, Agnes Bugajska-Schretter, Alexander Dohnal, Christine Ruf, Romana Gugenberger, Astrid Hagelkruys, Nuria Montserrat, Ivona Kozieradzki, Omar Hasan Ali, Johannes Stadlmann, Michael R. Holbrook, Connie Schmaljohn, Chris Oostenbrink, Robert H. Shoemaker, Ali Mirazimi, Gerald Wirnsberger, Josef M. Penninger

Summary: The emergence of multiple SARS-CoV-2 variants has raised concerns due to reduced vaccine efficacy and resistance to neutralizing antibody therapies. However, research shows that soluble ACE2 can inhibit current SARS-CoV-2 variants, providing proof of principle for a pan-SARS-CoV-2 therapeutic.

EMBO MOLECULAR MEDICINE (2022)

Article Multidisciplinary Sciences

Broadly neutralizing antibodies target the coronavirus fusion peptide

Cherrelle Dacon, Courtney Tucker, Linghang Peng, Chang-Chun D. Lee, Ting-Hui Lin, Meng Yuan, Yu Cong, Lingshu Wang, Lauren Purser, Jazmean K. Williams, Chul-Woo Pyo, Ivan Kosik, Zhe Hu, Ming Zhao, Divya Mohan, Andrew J. R. Cooper, Mary Peterson, Jeff Skinner, Saurabh Dixit, Erin Kollins, Louis Huzella, Donna Perry, Russell Byrum, Sanae Lembirik, David Drawbaugh, Brett Eaton, Yi Zhang, Eun Sung Yang, Man Chen, Kwanyee Leung, Rona S. Weinberg, Amarendra Pegu, Daniel E. Geraghty, Edgar Davidson, Iyadh Douagi, Susan Moir, Jonathan W. Yewdell, Connie Schmaljohn, Peter D. Crompton, Michael R. Holbrook, David Nemazee, John R. Mascola, Ian A. Wilson, Joshua Tan

Summary: This study identified six monoclonal antibodies that bind to spike proteins from all seven human-infecting coronaviruses. Two of these antibodies, COV44-62 and COV44-79, showed broad neutralizing activity against alpha- and betacoronaviruses, including the Omicron subvariants of SARS-CoV-2. The fusion peptide region in the spike protein was found to be a potential candidate epitope for next-generation coronavirus vaccine development.

SCIENCE (2022)

Article Virology

Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method

Renuka Rao, Melad Farraha, Grant J. Logan, Sindhu Igoor, Cindy Y. Kok, James J. H. Chong, Ian E. Alexander, Eddy Kizana

Summary: This study compared two production methods for cardiotropic rAAVs, finding that rAAV produced by the traditional HEK293 method outperformed vector produced using the baculovirus/Sf9 system in vitro and in vivo. This underscores the importance of thorough assessment of vector performance when using diverse rAAV production methods.

VIRUSES-BASEL (2022)

Article Multidisciplinary Sciences

Endosomal LC3C-pathway selectively targets plasma membrane cargo for autophagic degradation

Paula P. Coelho, Geoffrey G. Hesketh, Annika Pedersen, Elena Kuzmin, Anne-Marie N. Fortier, Emily S. Bell, Colin D. H. Ratcliffe, Anne-Claude Gingras, Morag Park

Summary: This study uncovers an LC3C-Endocytic-Associated-Pathway (LEAP) that selectively recruits plasma membrane cargo to autophagosomes, providing new understanding of the selective coupling of plasma membrane signaling with autophagic degradation.

NATURE COMMUNICATIONS (2022)

Article Biology

CryoEM of endogenous mammalian V-ATPase interacting with the TLDc protein mEAK-7

Yong Zi Tan, Yazan M. Abbas, Jing Ze Wu, Di Wu, Kristine A. Keon, Geoffrey G. Hesketh, Stephanie A. Bueler, Anne-Claude Gingras, Carol Robinson, Sergio Grinstein, John L. Rubinstein

Summary: CryoEM analysis revealed an interaction between mEAK-7 and V-ATPase, which is disrupted by ATP-induced rotation. Exogenous mEAK-7 does not inhibit V-ATPase activity unlike its yeast homolog.

LIFE SCIENCE ALLIANCE (2022)

Article Biochemistry & Molecular Biology

Recombinant Adeno-Associated Viral Vector-Mediated Gene Transfer of hTBX18 Generates Pacemaker Cells from Ventricular Cardiomyocytes

Melad Farraha, Renuka Rao, Sindhu Igoor, Thi Y. L. Le, Michael A. Barry, Christopher Davey, Cindy Kok, James J. H. Chong, Eddy Kizana

Summary: This study aimed to develop a biological alternative to electronic pacemakers by using gene therapy to convert cardiomyocytes into sinoatrial node-like cells. The results showed that the transduction of hTBX18 gene resulted in morphological, molecular, physiological, and functional changes in the cardiomyocytes, recapitulating the pacemaker phenotype. The use of a clinically relevant vector opens new prospects for the development of biological pacemakers.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cardiac & Cardiovascular Systems

Tropoelastin Improves Post-Infarct Cardiac Function

Robert D. Hume, Shaan Kanagalingam, Tejas Deshmukh, Siqi Chen, Suzanne M. Mithieux, Fairooj N. Rashid, Iman Roohani, Juntang Lu, Tram Doan, Dinny Graham, Zoe E. Clayton, Eugene Slaughter, Eddy Kizana, April S. Stempien-Otero, Paula Brown, Liza Thomas, Anthony S. Weiss, James J. H. Chong

Summary: This study demonstrated that tropoelastin can improve post-MI healing by enhancing cardiac repair and reducing scar formation. Tropoelastin injection significantly improved left ventricular function, reduced scar size, and increased scar elastin content. Furthermore, it promoted elastic fiber formation and reduced immune response. The findings suggest potential therapeutic strategies for manipulating scar synthesis after MI.

CIRCULATION RESEARCH (2023)

Review Cardiac & Cardiovascular Systems

Focal Anticoagulation by Somatic Gene Transfer: Towards Preventing Cardioembolic Stroke

Megha Kadian, Cindy Y. Kok, Dhanya Ravindran, Freda Passam, Leonardo Pasalic, Eddy Kizana

Summary: Cardioembolic stroke is a leading cause of ischemic stroke, and current therapeutic options are limited. Atrial appendage occlusion devices can be used for patients ineligible for oral anticoagulants, but there are still risks and limitations. Gene therapy is a promising strategy to target the underlying cause of cardioembolic stroke and further research is needed.

HEART LUNG AND CIRCULATION (2023)

Article Cell Biology

Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines

Thayne H. Dickey, Rui Ma, Sachy Orr-Gonzalez, Tarik Ouahes, Palak Patel, Holly McAleese, Brandi Butler, Elizabeth Eudy, Brett Eaton, Michael Murphy, Jennifer L. Kwan, Nichole D. Salinas, Michael R. Holbrook, Lynn E. Lambert, Niraj H. Tolia

Summary: Continued vaccination against SARS-CoV-2 is necessary due to waning immunity and emerging variants. A nanoparticle vaccine displaying the spike receptor-binding domain (RBD) has been developed, with improvements in stability, immune response, and manufacturing ease. The engineered RBD nanoparticles elicit potent neutralizing antibodies that surpass monomeric RBDs, providing protection against emerging variants.

CELL REPORTS (2023)

Article Multidisciplinary Sciences

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Dinesh Selvakumar, Emma Wilkie, Tejas Deshmukh, Dhanya Ravindran, Yasuhito Kotake, Juntang Lu, Tony Barry, Vu Tran, Hugh Paterson, Alfred Hing, Timothy Campbell, Saurabh Kumar, Eddy Kizana, James J. H. Chong

Summary: Myocardial infarction is a major cause of death and disability worldwide, and new cardioprotective or regenerative strategies are urgently needed. Physiologically relevant large animal models are crucial for assessing the feasibility and effectiveness of therapeutic delivery strategies. Swine, due to their similarities to humans in cardiovascular physiology and anatomy, are preferred in preclinical evaluation of new therapies for myocardial infarction.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2023)

Article Biochemistry & Molecular Biology

Promoter Optimization Circumvents Bcl-2 Transgene-Mediated Suppression of Lentiviral Vector Production

Cindy Y. Kok, Lauren M. MacLean, Renuka Rao, Shinya Tsurusaki, Eddy Kizana

Summary: The study aimed to identify a gene that can be delivered to the heart to protect against cancer therapy-induced cardiotoxicity. By replacing the CMV promoter with the cardiac-specific NCX1 promoter, a lentiviral vector capable of inducing the expression of cardioprotective gene Bcl-2 was successfully produced.

BIOMOLECULES (2023)

No Data Available